TERT and thyroid gland carcinoma: The most aggressive thyroid cancers, including PDTCs and ATCs, exhibited the highest frequencies of TERT promoter mutations; (II) C228T was found as the predominant mutation, and the presence of C228T and C250T was generally mutually exclusive.